Analysts on Wall Street project that RenaissanceRe (RNR) will announce quarterly loss of $0.23 per share in its forthcoming report, representing a decline of 101.9% year over year. Revenues are projected to reach $2.9 billion, increasing 2.4% from the same quarter last year. The consensus EPS estimate for the quarter has undergone an upward revision of 1.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. With that in mind, let's delve into the average projections of some RenaissanceRe metrics that are commonly tracked and projected by analysts on Wall Street. The combined assessment of analysts suggests that 'Revenues- Net premiums earned' will likely reach $2.47 billion. The estimate suggests a change of +1.3% year over year. The average prediction of analysts places 'Revenues- Equity in earnings (losses) of other ventures' at $9.43 million. The estimate points to a change of -33.3% from the year-ago quarter. Analysts forecast 'Revenues- Net investment income' to reach $428.77 million. The estimate points to a change of +9.7% from the year-ago quarter. It is projected by analysts that the 'Net premiums earned- Property' will reach $956.47 million. The estimate points to a change of +2.2% from the year-ago quarter. Analysts predict that the 'Underwriting Expense Ratio - Casualty and Specialty' will reach 32.4%. The estimate compares to the year-ago value of 32.5%. According to the collective judgment of analysts, 'Net Claims and Claim Expense Ratio - calendar year' should come in at 82.9%. The estimate is in contrast to the year-ago figure of 47.7%. The consensus among analysts is that 'Underwriting Expense Ratio' will reach 30.2%. The estimate is in contrast to the year-ago figure of 30.2%. Based on the collective assessment of analysts, 'Net Claims and Claim Expense Ratio - calendar year - Casualty and Specialty' should arrive at 71.4%. The estimate compares to the year-ago value of 67.1%. Story Continues Analysts expect 'Combined Ratio' to come in at 113.1%. The estimate compares to the year-ago value of 77.9%. The collective assessment of analysts points to an estimated 'Combined Ratio - Casualty and Specialty' of 103.7%. The estimate is in contrast to the year-ago figure of 99.6%. Analysts' assessment points toward 'Combined Ratio - Property' reaching 126.7%. The estimate is in contrast to the year-ago figure of 42.9%. The consensus estimate for 'Underwriting Expense Ratio - Property' stands at 27.5%. The estimate is in contrast to the year-ago figure of 26.4%. View all Key Company Metrics for RenaissanceRe here>>> Shares of RenaissanceRe have demonstrated returns of +1.8% over the past month compared to the Zacks S&P 500 composite's -5.6% change. With a Zacks Rank #3 (Hold), RNR is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RenaissanceRe Holdings Ltd. (RNR):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
RenaissanceRe (RNR) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...